Skip to content

IAS: Virological failure rare in patients taking saquinavir / ritonavir

IAS: New tablet formulation of Kaletra is on its way, manufacturer says

IAS: ‘Next generation’ NNRTI GW695634 is safe and active in NNRTI-resistant patients

IAS: Needle-free T-20 delivery reduces, but does not eliminate, injection site reactions (corrected)

IAS: Remune slows viral load rise and CD4 cell count fall during treatment interruptions

IAS: New NRTI D-d4FC active in treatment-experienced patients

UK international HIV funding increased

IAS: Tipranavir combined with T-20 achieves good virologic results in the highly treatment experienced

IAS: Two studies suggest that it may be possible to screen for acute primary HIV infections in sub-Saharan Africa